Cargando…

Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation

AIM: To determine whether diabetes mellitus (DM) affects prognosis/recurrence after liver transplantation (LT) for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). METHODS: A retrospective study was conducted between January 2000 and August 2013 on 1631 patients with HBV-related HCC w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qing, Deng, Yong-Lin, Liu, Chang, Huang, Li-Hong, Shang, Lei, Chen, Xin-Guo, Wang, Le-Tian, Du, Jin-Zan, Wang, Ying, Wang, Pei-Xiao, Zhang, Hui, Shen, Zhong-Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2016
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116601/ https://www.ncbi.nlm.nih.gov/pubmed/27920478 http://dx.doi.org/10.3748/wjg.v22.i43.9571

Ejemplares similares

Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
por: Li, Man-Yu, et al.
Publicado: (2023)

Percutaneous radiofrequency ablation is superior to hepatic resection in patients with small hepatocellular carcinoma
por: Zhang, Yan-Hua, et al.
Publicado: (2020)

Body mass index does not affect the survival of pancreatic cancer patients
por: Jiang, Qing-Long, et al.
Publicado: (2017)

On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chronic hepatitis B
por: Gao, Yu-Hua, et al.
Publicado: (2016)

High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation
por: He, Jia-Jia, et al.
Publicado: (2021)

Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma
por: Wang, Qiang, et al.
Publicado: (2019)

Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus
por: Wu, Meng-Jiao, et al.
Publicado: (2021)

Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis
por: Li, Shao-Hua, et al.
Publicado: (2017)

Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinoma
por: Ismail, Mohamed Saleh, et al.
Publicado: (2020)

Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy
por: Zhang, Hang-Yu, et al.
Publicado: (2018)

The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis
por: Zhang, Qing, et al.
Publicado: (2012)

Comparison of survival between adolescent and young adult vs older patients with hepatocellular carcinoma
por: Ren, Jie, et al.
Publicado: (2020)

Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma
por: Tang, You-Yin, et al.
Publicado: (2021)

Clinical characteristics and outcome of primary hepatic neuroendocrine tumors after comprehensive therapy
por: Wang, Hao-Hao, et al.
Publicado: (2020)

Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival
por: Yang, Hao-Jie, et al.
Publicado: (2016)

Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study
por: Yang, Dan-Hong, et al.
Publicado: (2021)

Factors associated with 5-year survival of combined hepatocellular and cholangiocarcinoma
por: Sempokuya, Tomoki, et al.
Publicado: (2020)

Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China
por: Lei, Ming, et al.
Publicado: (2018)

Outcomes associated with the intention of loco-regional therapy prior to living donor liver transplantation for hepatocellular carcinoma
por: Wu, Tsung-Han, et al.
Publicado: (2020)

Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resections
por: Lai, Yin, et al.
Publicado: (2022)

Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma
por: Deng, Peng-Zhan, et al.
Publicado: (2022)

Accurate ultrasonography-based portal pressure assessment in patients with hepatocellular carcinoma
por: Zhang, Yu, et al.
Publicado: (2020)

Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation
por: Chao, Jia-Shuo, et al.
Publicado: (2019)

Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model
por: Luo, Pan-Quan, et al.
Publicado: (2022)

Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus
por: Zhu, Lin-Zhong, et al.
Publicado: (2018)

Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
por: Tajiri, Kazuto, et al.
Publicado: (2022)

Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels
por: She, Wong Hoi, et al.
Publicado: (2018)

Postoperative survival analysis and prognostic nomogram model for patients with portal hypertension
por: Zhang, Ya-Fei, et al.
Publicado: (2018)

Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population
por: Ma, Ka Wing, et al.
Publicado: (2019)

Survival benefits and disparities in radiation therapy for elderly patients with pancreatic ductal adenocarcinoma
por: Cao, Bi-Yang, et al.
Publicado: (2023)

Prognostic model of hepatocellular carcinoma based on cancer grade
por: Zhang, Guo-Xin, et al.
Publicado: (2023)

Influence of postoperative complications on long-term survival in liver transplant patients
por: Castanedo, Sonia, et al.
Publicado: (2020)

Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level
por: Eshraghian, Ahad, et al.
Publicado: (2017)

IFIT1 polymorphisms predict interferon-α treatment efficiency for hepatitis B virus infection
por: Xie, Dong-Ying, et al.
Publicado: (2016)

Liver transplantation with simultaneous splenectomy increases risk of cancer development and mortality in hepatocellular carcinoma patients
por: Fan, Hsiu-Lung, et al.
Publicado: (2022)

Diagnosis of morbid obesity may not impact healthcare utilization for orthotopic liver transplantation: A propensity matched study
por: Peck, Joshua R, et al.
Publicado: (2017)

Safety of fecal microbiota transplantation in Chinese children: A single-center retrospective study
por: Zhang, Xin-Yue, et al.
Publicado: (2018)

Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus
por: Cao, Xi, et al.
Publicado: (2020)

Intra-arterial thrombolysis for early hepatic artery thrombosis after liver transplantation
por: Li, Ting, et al.
Publicado: (2021)

Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus
por: Zhang, Zi-Han, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_se5saucoq191ejm7pfe7nktu9h